Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 6
Abstract
Secondary hyperparathyroidism (SHPT), as a common complication of chronic renal failure, has always been a focus of clinical research on the treatment of parathyroidism. The pathogenesis of SHPT is due to the abnormal secretion of parathyroid hormone caused by changes in the internal environment of the human body after the progression of chronic kidney disease to the end stage, resulting in the secretion and metabolic disorders of calcium and phosphorus plasma, leading to serious complications of functional disorders in various systems including the urinary system, skeletal system, cardiovascular system, and even the whole body. This article reviews the current status of surgical treatment of SHPT in patients with chronic kidney disease at home and abroad, in order to increase surgeons' understanding of surgical treatment, so as to provide patients with better surgical treatment program guidance and improve the quality of life of patients with SHPT.
Authors and Affiliations
MA Ziyue, ZHANG Yilun
Keywords
Related Articles
- EP ID EP738451
- DOI 10.13429/j.cnki.cjcr.2024.06.027
- Views 26
- Downloads 0
The role of different complement activation pathways in diabetic kidney disease and related treatment strategies
Diabetic kidney disease (DKD) is one of the common serious complications in diabetic patients. Its development and progression process is very complex, and the treatment options are limited. This paper reviews the roles...
Effects of unicondylar and total knee arthroplasty on knee osteoarthritis
<b>Objective</b> To compare the therapeutic effects of unicondylar knee arthroplasty (UKA) and total knee arthroplasty (TKA) on knee osteoarthritis (KOA) to provide references for the clinical selection of the best surg...
Effect of serum monocyte chemotactic protein-2 and growth differentiation factor-15 on suicidal ideation in patients with major depressive disorder
Objective To analyze the correlation between serum monocyte chemotactic protein-2 (MCP-2), growth differentiation factor-15 (GDF-15) and personality characteristics of patients with major depressive disorder (MDD) and t...
Efficacy and safety of argatroban combined with plasmin in the treatment of acute cerebral infarction
Objective To observe the effects of combined application of argatroban and plasmin on the degree of neurological function deficit and neutrophil (NEUT) count in patients with acute cerebral infarction (ACI) and their sa...
Research progress and treatment status of non-ischemic cardiomyopathy
Cardiomyopathy is a heart disease clinically characterized by enlargement of the heart, arrhythmia and heart failure alone or simultaneously. Ischemic cardiomyopathy is usually caused by coronary atherosclerotic lesions,...